Investing Profile

Matthew De Silva

InvestorVCAngel
Venture Partner at Builders VC
builders.vcChicago, Illinois
Photo of Matthew De Silva, Venture Partner at Builders VC

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Builders VC Venture Partner
$100K - $5.0M
$1.5M
3
CompanyStageDateRound SizeTotal Raised
Eigen Therapeutics
SeedDec 2022$7M
$7M
Co-investors: Ludwig Schulze (Alumni Ventures ), Josh Kopelman (First Round Capital), Supachai Kid Parchariyanon (SeaX Ventures), Supachai Kid Parchariyanon (HOF Capital), Milad Alucozai (Entrepreneur First), Varsha Rao (Nurx), Kevin Mahaffey (Lookout), Jano Búza (ZAKA Ventures)
Arpeggio Bio
Series ASep 2022$17M
$20M
Co-investors: Amit Mehta (Builders VC), Milad Alucozai (Entrepreneur First), Alice Zhang
Enveda Biosciences
Series AJun 2021$51M
$500M
Co-investors: Rohit Sharma (True Ventures), Zavain Dar (Dimension Capital), Pegah Ebrahimi (FPV Fund), Christian Scherrer (Kinnevik), Pablo Lubroth (Future Planet Capital), rajiv chegu (Serent Capital), Henry Kravis, Chris Gibson